Skip to main content

Food and Drug Administration

Sharing New Research on Vaccinology

Leading global experts will share cutting-edge research on addressing vaccine hesitancy and new vaccines to prevent Zika, dengue, influenza, and antimicrobial resistance in Baltimore at the NFID 2019 Annual Conference on Vaccinology Research…

ID News Round-Up

Recent items of interest from the world of infectious diseases including the latest influenza vaccine recommendations, new policies from AAP to boost childhood immunization rates, new guidelines for the treatment of common sexually transmitted diseases, Zika in the US, and the FDA ban on some common antibacterial ingredients in soaps and body washes.

Working Towards a Universal Influenza Vaccine

A universal influenza vaccine would be an exciting new advancement and would revolutionize a vaccination strategy that has remained largely unchanged for over 50 years. An attractive future is on the rise in which an individual would need to receive only two vaccinations over his or her lifetime to protect against the many commonly circulating influenza virus strains, as well as possible emergent pandemic strains.

Focusing on Today’s Challenges to Deliver Tomorrow’s Vaccines

Advances in science and technology are giving rise to research and development for new vaccines. Additionally, innovative manufacturing approaches are being applied in the production of these products. This is especially true for vaccines necessary to address global patient population needs in developing countries and international markets.

Vaccine Safety: What You Should Know

The independent and multi-layered vaccine review process can be complicated but is in place to ensure that vaccines are held to the highest standards of safety. Moreover, continuous monitoring of health problems after vaccination ensures that the US has a safe and effective vaccine supply.

Meningitis B Vaccine: Part of the Routine Vaccine Schedule?

Adding a vaccine to the recommended schedule is not without controversy. All vaccines cost money—the meningococcal B vaccine costs around $130 a dose and currently the two vaccines available are part of a 2- or 3-dose series. However, the benefits of vaccination far out weigh the cost of vaccination.

Clostridium difficile Infection: Is Hope on the Horizon?

Special thanks to Irena L. Kenneley, PhD, APRN-BC, CIC and Carol McLay, RN, MPH, DrPH, CIC, both members of the Association for Professionals in Infection Control and Epidemiology (APIC) Communications Committee, for this guest blog on the promise of a Clostridium difficile vaccine. Clostridium difficile (C. diff) is a potentially life-threatening bacterium that causes diarrhea and more serious intestinal conditions. It is frequently…